A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 27 150 KRW 2.84% Market Closed
Market Cap: 1.3T KRW
Have any thoughts about
ABL Bio Inc?
Write Note

ABL Bio Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ABL Bio Inc
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
A
ABL Bio Inc
KOSDAQ:298380
Net Change in Cash
-â‚©30.3B
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Net Change in Cash
â‚©611.2B
CAGR 3-Years
33%
CAGR 5-Years
28%
CAGR 10-Years
54%
SK Bioscience Co Ltd
KRX:302440
Net Change in Cash
-â‚©98.3B
CAGR 3-Years
N/A
CAGR 5-Years
-120%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Net Change in Cash
â‚©53B
CAGR 3-Years
N/A
CAGR 5-Years
-15%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Net Change in Cash
â‚©50.8B
CAGR 3-Years
74%
CAGR 5-Years
59%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Net Change in Cash
â‚©4.6B
CAGR 3-Years
-26%
CAGR 5-Years
62%
CAGR 10-Years
N/A
No Stocks Found

ABL Bio Inc
Glance View

Market Cap
1.3T KRW
Industry
Biotechnology

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

Intrinsic Value
8 401.38 KRW
Overvaluation 69%
Intrinsic Value
Price
A

See Also

What is ABL Bio Inc's Net Change in Cash?
Net Change in Cash
-30.3B KRW

Based on the financial report for Jun 30, 2024, ABL Bio Inc's Net Change in Cash amounts to -30.3B KRW.

What is ABL Bio Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
-1%

The average annual Net Change in Cash growth rates for ABL Bio Inc have been -1% over the past three years .

Back to Top